The need for contraception in the successful management of captive wild animals is becoming increasingly apparent. Because concerns exist regarding the reversibility of the contraceptive implant melengestrol acetate (MGA), reproductive data for 94 female Amur (Panthera tigris altaica) and Sumatran tigers (Panthera tigris sumatrae) were analyzed using survival analyses to evaluate return to reproductive status after implant removal or assumed expiration. Females placed in potential breeding situations after MGA implants were surgically removed showed a 62% return to reproduction by 5.25 years, whereas females with implants that were assumed to have expired showed only a 30% return to reproduction by 6 years. Implanted females did not reproduce as successfully as non-implanted control females, which showed an 85% probability of reproducing after placement in a new breeding situation by 2.66 years. Parturition increased the probability of reproducing in non-implanted females, but not in implanted females. Litter size, stillbirths, and offspring survival were not significantly different between non-implanted, implant-removed and implantexpired female tigers. Ten female tigers reproduced both before and after implant placement, and the differences in litter size, stillbirths, and offspring survival were not significant, nor were they significantly different from non-implanted females. Prior parturition, age when implant was removed, and duration of implantation did not affect the probability of reproducing for females after implant removal. These results show substantial reversibility of MGA implants, leading to 62% successful reproduction after implant removal. The reasons for lower successful reproduction in animals previously treated with the contraceptive compared to non-implanted females are not known, but a greater delay in reversibility was seen when implants were left in place and only presumed expired. Zoo Biol 26: 275-288, 2007.

Melengestrol acetate (MGA) implants were used for contraception in three addax and three Arabian oryx females housed at the Saint Louis Zoo. Serum estradiol and progesterone or fecal estrogen and progestin analysis and ultrasonography of reproductive tracts were used for monitoring changes before, during, and after MGA treatment. Follicular development and irregular uterine fluid accumulation were detected in all females during MGA treatment. Although housed with an intact male for all or most of the contraceptive period, no pregnancies occurred.One female addax may have ovulated, based on sustained elevated progesterone levels, and another showed continued follicle development, as seen by fluctuating estradiol concentrations. Reversibility was documented in two of the three addax that resumed reproductive cycles post-MGA-implant removal, whereas the third, a peripubertal female, did not cycle before, during, or after treatment. Addax females were lost to further follow-up after transfer to another institution, so the possibility of subsequent pregnancies is not known.All three Arabian oryx ovulated during the initial MGA treatment, but two of the three females had implants past the typical 2-year efficacy period. They had regular ovulatory cycles after implant removal, with mean cycle length of 27.5+/-1.5 days and mean luteal phase duration of 15.2+/-0.7 days. Reversibility was further shown in all three oryx by pregnancies after placement with a male approximately 2 years after MGA implant removal. Two produced healthy calves, but the third died owing to an unrelated terminal illness in the mother. Zoo Biol 26:299-310, 2007. (c) 2007 Wiley-Liss, Inc.